Show results for
Refine by
Cancer Recurrence Equipment & Supplies In Grenada
11 equipment items found
Manufactured by:Cerca Biotech based inBerlin, GERMANY
Upon binding of progesterone, the receptor is activated and modifies expression of several downstream genes. Estrogen and progesterone receptors are found in Breast Cancer cells that depend on estrogen and related hormones (such as progesterone) to grow. All patients with invasive Breast Cancer or a Breast Cancer recurrence ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Prostate cancer is one of the leading causes of morbidity and mortality in men in the western world, and the second most common cancer in men worldwide. Imaging of the prostate-specific membrane antigen (PSMA) has become an essential tool for managing patients with recurrent prostate cancer and 68Ga PSMA-11 is one of the most ...
Manufactured by:Dilon Technologies Inc. based inNewport News, VIRGINIA (USA)
The Dilon Navigator provides the best gamma probe value in the market. The Dilon Navigator 2.0 combines the reliability and features of its predecessor, the Navigator GPS, with state-of-the-art wireless probe technology in a new, sleek design. Lightweight and compact, this system is the ultimate in portability and the advanced battery technology allows for optimal placement of the control unit in ...
Manufactured by:Pyrexar based inSalt Lake City, UTAH (USA)
BSD-500 Superficial Hyperthermia a versatile, fully self-contained treatment system in a mobile configuration or maximum treatment flexibility of superficial tumors within 1” of skin surface. ...
by:F. Hoffmann-La Roche Ltd. based inBasel, SWITZERLAND
Avastin is a monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A). With the initial approval in the United States for advanced colorectal cancer in 2004, Avastin became the first anti-angiogenic therapy made widely available for the treatment of patients with an advanced ...
Manufactured by:Shanghai Henlius Biotech, Inc based inShanghai, CHINA
HANBEITAI (bevacizumab injection) was approved by the NMPA in November 2021. It is indicated for metastatic colorectal cancer (mCRC), advanced, metastatic or recurrent non-small cell lung cancer (NSCLC), recurrent glioblastoma, cervical cancer, epithelial ovarian cancer, fallopian tube ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Immunoscore® for Rectal Cancer can help identify patients with LARC who are at a low risk of relapse and may be good candidates for organ preservation. Immunoscore® is available through an Innovation Access Program while the company conducts clinical validation ...
Manufactured by:Jubilant DraxImage Inc. dba Jubilant Radiopharma based inKirkland, Montréal, QUEBEC (CANADA)
The concentrated solution (1 Ci per mL) is intended for use in the preparation of capsules and solution of varying strengths for oral administration for ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Niraparib (MK-4827) tosylate hydrate is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib tosylate hydrate leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...